Life Science Investing Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang 01 October
Life Science Investing Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors 23 September
Life Science Investing Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference 08 September
